Share-based Payment Arrangement, Expense of BIOXYTRAN, INC from 31 Dec 2022 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
BIOXYTRAN, INC quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2022 to 31 Mar 2025.
  • BIOXYTRAN, INC Share-based Payment Arrangement, Expense for the quarter ending 31 Mar 2025 was $28,600, a 90% decline year-over-year.
  • BIOXYTRAN, INC annual Share-based Payment Arrangement, Expense for 2024 was $634,025, a 257% increase from 2023.
  • BIOXYTRAN, INC annual Share-based Payment Arrangement, Expense for 2023 was $177,421, a 0.54% decline from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

BIOXYTRAN, INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $28,600 -$271,645 -90% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q1 2024 $300,245 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1

BIOXYTRAN, INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $634,025 +$456,604 +257% 01 Jan 2024 31 Dec 2024 10-K 03 Apr 2025 2024 FY
2023 $177,421 -$961 -0.54% 01 Jan 2023 31 Dec 2023 10-K 03 Apr 2025 2024 FY
2022 $178,382 01 Jan 2022 31 Dec 2022 10-K/A 13 Jan 2025 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.